Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Net Cash Flow (2016 - 2025)

InspireMD's Net Cash Flow history spans 16 years, with the latest figure at -$54.5 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 1883.31% year-over-year to -$54.5 million; the TTM value through Dec 2025 reached -$10.1 million, down 16.98%, while the annual FY2025 figure was -$10.1 million, 209.42% down from the prior year.
  • Net Cash Flow reached -$54.5 million in Q4 2025 per NSPR's latest filing, down from $51.8 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $51.8 million in Q3 2025 to a low of -$54.5 million in Q4 2025.
  • Average Net Cash Flow over 5 years is -$3.0 million, with a median of -$1.2 million recorded in 2021.
  • Peak YoY movement for Net Cash Flow: skyrocketed 1434.03% in 2021, then tumbled 2565.59% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$1.1 million in 2021, then surged by 165.19% to $691000.0 in 2022, then plummeted by 709.7% to -$4.2 million in 2023, then surged by 172.51% to $3.1 million in 2024, then tumbled by 1883.31% to -$54.5 million in 2025.
  • Per Business Quant, the three most recent readings for NSPR's Net Cash Flow are -$54.5 million (Q4 2025), $51.8 million (Q3 2025), and -$874000.0 (Q2 2025).